Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone

• Published in: American journal of physiology. Lung cellular and molecular physiology Vol. 323; no. 4; pp. L473 - L483
• Main Authors: Dey, Surajit, Lu, Wenying, Weber, Heinrich C, Young, Sally, Larby, Josie, Chia, Collin, Haug, Greg, Brake, Samuel James, Myers, Stephen, Gaikwad, Archana Vijay, Bhattarai, Prem, Pathinayake, Prabuddha S, Wark, Peter A B, Eapen, Mathew Suji, Sohal, Sukhwinder Singh
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.10.2022
• Subjects: Airway Remodeling; Asthma; Cross-Sectional Studies; Humans; Pulmonary Disease, Chronic Obstructive - pathology; Smokers; asthma COPD overlap; asthma; airway remodeling; smoking; COPD
• ISSN: 1040-0605; 1522-1504
• DOI: 10.1152/ajplung.00137.2022

Management of patients with asthma COPD overlap (ACO) is clinically challenging due to insufficient evidence of pathological changes in these patients. In this cross-sectional study, we evaluated airway remodeling in endobronchial biopsies from a total of 90 subjects, which included 12 ACO, 14 patients with asthma, 12 COPD exsmokers (ES), 11 current smokers (CS), 28 healthy controls (HC), and 13 normal lung function smokers (NLFS). Tissue was stained with Masson's trichrome. Epithelium, goblet cells, reticular basement membrane (RBM), cellularity, lamina propria (LP), and smooth muscle (SM) changes were measured using Image-Pro Plus v7 software. Differential airway remodeling pattern was seen in patients with ACO. A limited change was noted in the ACO epithelium compared with other pathological groups. RBM was substantially thicker in patients with ACO than in HC ( < 0.0002) and tended to be thicker than in patients with asthma and NLFS. The total RBM cells were higher in ACO than in the HC ( < 0.0001), COPD-CS ( = 0.0559), -ES ( = 0.0345), and NLFS ( < 0.0002), but did not differ from patients with asthma. Goblet cells were higher in the ACO than in the HC ( = 0.0028) and COPD-ES ( = 0.0081). The total LP cells in ACO appeared to be higher than in HC, COPD-CS, and NLFS but appeared to be lower than in patients with asthma. Finally, SM area was significantly lower in the ACO than in patients with asthma ( = 0.001), COPD-CS (=0.0290), and NLFS ( = 0.0011). This first comprehensive study suggests that patients with ACO had distinguishable tissue remodeling that appeared to be more severe than patients with asthma and COPD. This study will help in informed decision-making for better patient management in clinical practice.